In laboratories and data centers alike, a new kind of life is being imagined into existence — not biological, but mathematical. Researchers have built four-dimensional AI models of human cells, digital twins capable of responding to pharmaceutical compounds in simulation, offering science a way to ask nature's questions before nature must answer them in flesh. The technology, championed in part by UAE authorities through the AIDO Cell model, promises to compress the long, costly arc of drug discovery by filtering out failing candidates before a single physical experiment begins. It is, at its